Current and Future Trends in Big Data Utilization Across Medical Affairs Functions

Feb 05, 2016, 18:30 ET from Best Practices, LLC

CHAPEL HILL, N.C., Feb. 5, 2016 /PRNewswire/ -- Despite the recent explosion in Big Data, the biopharmaceutical sector has been slower than other industries to embrace Big Data due to the inherent costs and challenges that come with utilization. On the medical side, organizations have begun looking to Big Data as a way to improve everything from clinical trials to adherence.

According to recent research from benchmarking firm Best Practices, LLC, Big Data has started informing many decisions. In fact, all participating companies in the study leverage Big Data in some way. More than half- 53%- of study participants already have a Big Data team or function in place. Another 20% expect to have one within a year.

The related report, "Big Data in Pharma: Current & Future Trends for Big Data Utilization across Medical Affairs Functions," will help leaders to better understand the growing influence of Big Data in the biopharmaceutical sector and how it impacts medical, HEOR, and commercial operations in the U.S.

Key study topics covered include:

  • Types of Big Data Projects Used to Support Medical, Commercial, and HEOR Decisions
  • Big Data Capabilities and Governance
  • Types and Value of Data Used for Big Data Projects
  • Value Rating of Partnerships on Big Data Projects
  • Policies and Procedures Governing Big Data Activities

Best Practices, LLC engaged 12 leaders from 11 pharmaceutical companies through a benchmarking survey in regards to Big Data usage in Medical Affairs.

To access the full report, or to download a complimentary summary containing insights found in this report, click on the following link: http://www.best-in-class.com/rr1410.htm

For more information on other recent primary research studies, contact us at 919.403.0251. For related research, visit our Best Practices, LLC website at http://www.best-in-class.com/.

ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.

SOURCE Best Practices, LLC



RELATED LINKS

http://www.best-in-class.com